...
首页> 外文期刊>Emerging Infectious Diseases >First Characterization of a Cluster of VanA-Type Glycopeptide-Resistant Enterococcus faecium, Colombia
【24h】

First Characterization of a Cluster of VanA-Type Glycopeptide-Resistant Enterococcus faecium, Colombia

机译:哥伦比亚耐VanA型糖肽肠球菌簇的第一个表征

获取原文

摘要

From August 1998 to October 1999, glycopeptide-resistant enterococci (GRE) were isolated from 23infected patients at a teaching hospital in Medellín, Colombia. Identification at the species level and bymultiplex polymerase chain reaction assay indicated that all isolates were Enterococcus faecium. The iso-lates were highly resistant to ampicillin, ciprofloxacin, gentamicin, penicillin, streptomycin, teicoplanin, andvancomycin; they were susceptible only to chloramphenicol, linezolid, and nitrofurantoin. Determination ofglycopeptide genotype indicated the presence of the vanA gene in all isolates. Molecular typing by pulsedfield gel electrophoresis showed that all isolates were closely related. This study is the first molecular char-acterization of GRE in Colombia
机译:从1998年8月至1999年10月,在哥伦比亚麦德林的一家教学医院从23例受感染的患者中分离出了对糖肽耐药的肠球菌(GRE)。在物种水平上的鉴定和多重聚合酶链反应分析表明,所有分离物均为粪肠球菌。这些异构体对氨苄西林,环丙沙星,庆大霉素,青霉素,链霉素,替考拉宁和万古霉素具有高度耐药性。他们只对氯霉素,利奈唑胺和呋喃妥因敏感。糖肽基因型的确定表明所有分离物中都存在vanA基因。脉冲场凝胶电泳的分子分型显示所有分离株密切相关。这项研究是哥伦比亚GRE的首次分子表征

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号